JEFFREY SCHROEDER: Open Payments
NPI 1518270032 · PAOLA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$783 in 48 payments from 10 companies in 2025. Trend: 2023 $1,154 · 2024 $458 · 2025 $783
Food & beverage: $783
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $303 |
| AstraZeneca Pharmaceuticals LP | 4 | $202 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $82 |
| Ardelyx, Inc. | 3 | $64 |
| Exact Sciences Corporation | 2 | $37 |
| Axsome Therapeutics, Inc. | 2 | $33 |
| Novo Nordisk Inc | 1 | $17 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $16 |
| PFIZER INC. | 1 | $14 |
| Lilly USA, LLC | 1 | $14 |
Products named: VRAYLAR, FARXIGA, QULIPTA, CAPLYTA, IBSRELA, Auvelity, BREZTRI, The Cologuard Plus Collection Kit.
Industry payments across KS — which companies pay providers there.
